ArticleTargeted oncology2022

Do Early Phase Oncology Trials Predict Clinical Efficacy in Subsequent Biomarker-Enriched Phase III Randomized Trials?

Suji Udayakumar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.